Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-76.53M -51.69M -43.42M -46.63M -33.71M -28.38M -25.66M -20.1M -20.16M -30.07M -32.44M -24.68M -14.85M -17.09M -16.85M -7.61M -3.44M -4.71M
Depreciation & Amortization
119K 85K 55K 24K 1.5M -952K -635K -1.44M -971K -506K -597K -152K -106K 9K 32K 59K 50K 35K
Stock-Based Compensation
9.47M 7.74M 6.22M 5.59M 4.87M 4.12M 3.22M 2.92M 2.68M 2.67M 2.75M 2.45M 2.02M 1.66M 962K 933K 713K 404K
Other Working Capital
n/a -11.04M -3.79M 5.92M 6.69M -2.71M -895K -3.93M -7.87M 6.67M 3.56M -393K -6.95K -74K 3.87M 1.66M -3.43M 942K
Other Non-Cash Items
12.14M -1.1M -1.3M -1.73M 3.33M 8.13M 3.13M 549K 564K 580K 590K 4.42M 551K 564K 4.88M -125K -160K -590K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.13M 15K 29K n/a n/a n/a n/a n/a 247K 364K -2.41M n/a
Change in Working Capital
n/a -11.04M -728K 5.86M 6.14M -8.62M -2.08M -4.91M 86K 1.04M 8.54M -465K -7.19M 5.87M 4.29M 896K -2.42M 744K
Operating Cash Flow
-54.8M -54.41M -39.18M -36.88M -24.78M -33.83M -25.14M -22.97M -17.77M -26.29M -21.16M -18.42M -19.03M -8.98M -6.44M -5.48M -7.67M -4.12M
Capital Expenditures
-208K -187K -645K -25.11M 24.78M n/a -63K n/a n/a n/a -6K -38K -6K -18K n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -18.62K n/a n/a n/a n/a 2.4K n/a n/a n/a n/a 796K n/a
Purchase of Investments
-94.73M -92.52M -294.01M -72.94M -81.09M -254.97M -53.2M -28.67M -108.85M -34.21M -10.56M -40.4M -58.09M -39.44M n/a n/a n/a n/a
Sales Maturities Of Investments
126.06M 106.25M 73.28M 111.5M 58.5M 35.68M 71.82M 44.9M 22.4M 46.44M 24M 38M 16M n/a n/a n/a n/a n/a
Other Investing Acitivies
-2.58M 1.78M n/a 24.87M -89K -219.29K 18.62K 16.23K -86.45K 12.23K 6K -2.4K -42.09K -39.44K -5M n/a 796K n/a
Investing Cash Flow
28.54M 15.32M -221.38M 38.32M -22.68M -219.29M 18.56M 16.23M -86.45M 12.23M 13.44M -2.44M -42.09M -39.45M -5M n/a 796K n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K -1K
Common Stock Repurchased
n/a n/a n/a -13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
20.29M 1.53M n/a 752K 3.44M -11M 24.83M 297K 432K -7.02M 20.71M 907K 47K -5.86M 4.92M n/a -2.19M -27K
Financial Cash Flow
20.29M 1.53M 325.95M 739K 3.44M 276.54M 24.83M 297K 432K 107.98M 20.71M 908K 48K 80.27M 4.92M n/a 48.99M -28K
Net Cash Flow
-5.97M -37.56M 65.39M 2.17M -44.02M 23.42M 18.24M -6.45M -103.79M 93.93M 12.98M -19.95M -61.08M 31.83M -6.52M -5.48M 42.12M -4.15M
Free Cash Flow
-55.01M -54.59M -39.83M -61.99M n/a -33.83M -25.21M -22.97M -17.77M -26.29M -21.17M -18.46M -19.04M -9M -6.44M -5.48M -7.67M -4.12M